Suppr超能文献

不含血管性血友病因子的具有生物活性的低分子量人抗血友病因子的部分纯化。I. 部分特性鉴定及对有限还原敏感的二硫键的证据

Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.

作者信息

Harris R B, Newman J, Johnson A J

出版信息

Biochim Biophys Acta. 1981 May 29;668(3):456-70. doi: 10.1016/0005-2795(81)90180-x.

Abstract

Partially purified (approx. 5000-fold), low molecular weight human antihemophilic factor, free of detectable Von Willebrand factor (ristocetin cofactor activity or Von Willebrand antigen), was prepared from fresh citrated plasma by limited reduction with 1 mM dithiothreitol and chromatography on Sepharose CL-4B, Sephadex G-100, and polyelectrolyte E-5. The ratio of antihemophilic factor activity to Von Willebrand factor activity or antigen was greater than 27 000 : 1. The antihemophilic factor activity could be neutralized with homologous antibody and could be further increased with thrombin. The Mr (approx. 116 000) was determined by calibrated gel permeation chromatography, electrophoresis in 5% polyacrylamide gels with sodium dodecyl sulfate and by electrophoresis in large-pore acrylamide gels without it. Since the low Mr antihemophilic factor could be prepared by treating fresh rather than fresh-frozen plasma with dithiothreitol, it was concluded that partial reduction of the antihemophilic factor with this reagent helped to maintain the antihemophilic factor in a low Mr form. When iodo[l-14C]acetamide was used to alkylate the reduced plasma proteins prior to purification, the molecular weight of the purified antihemophilic factor remained low despite numerous purification steps. By this means, one of four radioactive proteins (Mr 116 000) in the final preparation was bound specifically to homologous antihemophilic factor antibody and attributed to 14C-labeled antihemophilic factor. While the data suggest that antihemophilic factor in fresh plasma contains one or more dithiothreitol-sensitive intramolecular disulfide bonds, the possibility of disulfide linkages with other proteins(s) cannot be excluded.

摘要

从新鲜枸橼酸盐血浆中,通过用1 mM二硫苏糖醇进行有限还原以及在琼脂糖CL - 4B、葡聚糖G - 100和聚电解质E - 5上进行色谱分离,制备了部分纯化(约5000倍)、低分子量的人抗血友病因子,该因子不含可检测到的血管性血友病因子(瑞斯托霉素辅因子活性或血管性血友病抗原)。抗血友病因子活性与血管性血友病因子活性或抗原的比率大于27000:1。抗血友病因子活性可用同源抗体中和,并用凝血酶进一步增强。通过校准的凝胶渗透色谱法、在含十二烷基硫酸钠的5%聚丙烯酰胺凝胶中进行电泳以及在不含十二烷基硫酸钠的大孔丙烯酰胺凝胶中进行电泳,测定了其Mr(约116000)。由于用二硫苏糖醇处理新鲜血浆而非新鲜冷冻血浆可制备低Mr抗血友病因子,因此得出结论,用该试剂对抗血友病因子进行部分还原有助于将抗血友病因子维持在低Mr形式。在纯化之前,当用碘[1 - 14C]乙酰胺对还原的血浆蛋白进行烷基化时,尽管经过了许多纯化步骤,纯化后的抗血友病因子的分子量仍保持较低。通过这种方法,最终制剂中的四种放射性蛋白之一(Mr 116000)与同源抗血友病因子抗体特异性结合,并归因于14C标记的抗血友病因子。虽然数据表明新鲜血浆中的抗血友病因子含有一个或多个对二硫苏糖醇敏感的分子内二硫键,但不能排除与其他蛋白质形成二硫键的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验